| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.0071 | 0.8 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.0071 | 0.8 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.0067 | 0.8 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | -0.027 | 0.8 |